Industry Research Reports
Home > Reports > Pharma & Healthcare > Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 130 Pages
Report ld: 3477296
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Heparin Market Size(US$)
CAGR 2025-2031
7.4%
Market Size,2031
USD 3,489
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,276 million
Market Forecast in 2031(Value)
US$ 3,489 million
CAGR
7.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Heparin was estimated to be worth US$ 2134 million in 2024 and is forecast to a readjusted size of US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
This report aims to provide a comprehensive presentation of the global market for Heparin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Heparin by region & country, by Type, and by Application.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (B Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
MARKET SEGMENTATION
By Company
- Shenzhen Hepalink Pharmaceutical
- Yantai Dongcheng Pharmaceutical
- Pfizer
- Bioibérica
- Changzhou Qianhong Biopharma
- Nanjing King-friend Biochemical Pharmaceutical
- Hebei Changshan Biochemical Pharmaceutical
- Qingdao Jiulong Biopharmaceutical
- Opocrin
- Dongying Tiandong Pharmaceutical
- Aspen Oss
- Yino Pharma
- Nanjing Xinbai Pharmaceutical
- Hubei Enoray Biopharmaceutical
- Cisen Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Heparin Sodium
- Heparin Calcium
Segment by Application
- UFH
- LMWH
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Heparin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Heparin Product Introduction
1.2 Global Heparin Market Size Forecast
1.2.1 Global Heparin Sales Value (2020-2031)
1.2.2 Global Heparin Sales Volume (2020-2031)
1.2.3 Global Heparin Sales Price (2020-2031)
1.3 Heparin Market Trends & Drivers
1.3.1 Heparin Industry Trends
1.3.2 Heparin Market Drivers & Opportunity
1.3.3 Heparin Market Challenges
1.3.4 Heparin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Heparin Players Revenue Ranking (2024)
2.2 Global Heparin Revenue by Company (2020-2025)
2.3 Global Heparin Players Sales Volume Ranking (2024)
2.4 Global Heparin Sales Volume by Company Players (2020-2025)
2.5 Global Heparin Average Price by Company (2020-2025)
2.6 Key Manufacturers Heparin Manufacturing Base and Headquarters
2.7 Key Manufacturers Heparin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Heparin
2.9 Heparin Market Competitive Analysis
2.9.1 Heparin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Heparin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Heparin Sodium
3.1.2 Heparin Calcium
3.2 Global Heparin Sales Value by Type
3.2.1 Global Heparin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Heparin Sales Value, by Type (2020-2031)
3.2.3 Global Heparin Sales Value, by Type (%) (2020-2031)
3.3 Global Heparin Sales Volume by Type
3.3.1 Global Heparin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Heparin Sales Volume, by Type (2020-2031)
3.3.3 Global Heparin Sales Volume, by Type (%) (2020-2031)
3.4 Global Heparin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 UFH
4.1.2 LMWH
4.2 Global Heparin Sales Value by Application
4.2.1 Global Heparin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Heparin Sales Value, by Application (2020-2031)
4.2.3 Global Heparin Sales Value, by Application (%) (2020-2031)
4.3 Global Heparin Sales Volume by Application
4.3.1 Global Heparin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Heparin Sales Volume, by Application (2020-2031)
4.3.3 Global Heparin Sales Volume, by Application (%) (2020-2031)
4.4 Global Heparin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Heparin Sales Value by Region
5.1.1 Global Heparin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Heparin Sales Value by Region (2020-2025)
5.1.3 Global Heparin Sales Value by Region (2026-2031)
5.1.4 Global Heparin Sales Value by Region (%), (2020-2031)
5.2 Global Heparin Sales Volume by Region
5.2.1 Global Heparin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Heparin Sales Volume by Region (2020-2025)
5.2.3 Global Heparin Sales Volume by Region (2026-2031)
5.2.4 Global Heparin Sales Volume by Region (%), (2020-2031)
5.3 Global Heparin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Heparin Sales Value, 2020-2031
5.4.2 North America Heparin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Heparin Sales Value, 2020-2031
5.5.2 Europe Heparin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Heparin Sales Value, 2020-2031
5.6.2 Asia Pacific Heparin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Heparin Sales Value, 2020-2031
5.7.2 South America Heparin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Heparin Sales Value, 2020-2031
5.8.2 Middle East & Africa Heparin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Heparin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Heparin Sales Value
6.2.1 Key Countries/Regions Heparin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Heparin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Heparin Sales Value, 2020-2031
6.3.2 United States Heparin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Heparin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Heparin Sales Value, 2020-2031
6.4.2 Europe Heparin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Heparin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Heparin Sales Value, 2020-2031
6.5.2 China Heparin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Heparin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Heparin Sales Value, 2020-2031
6.6.2 Japan Heparin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Heparin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Heparin Sales Value, 2020-2031
6.7.2 South Korea Heparin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Heparin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Heparin Sales Value, 2020-2031
6.8.2 Southeast Asia Heparin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Heparin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Heparin Sales Value, 2020-2031
6.9.2 India Heparin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Heparin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Information
7.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Product Offerings
7.1.5 Shenzhen Hepalink Pharmaceutical Recent Development
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Information
7.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Product Offerings
7.2.5 Yantai Dongcheng Pharmaceutical Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Pfizer Heparin Product Offerings
7.3.5 Pfizer Recent Development
7.4 Bioibérica
7.4.1 Bioibérica Company Information
7.4.2 Bioibérica Introduction and Business Overview
7.4.3 Bioibérica Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Bioibérica Heparin Product Offerings
7.4.5 Bioibérica Recent Development
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Company Information
7.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
7.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Changzhou Qianhong Biopharma Heparin Product Offerings
7.5.5 Changzhou Qianhong Biopharma Recent Development
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offerings
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
7.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Product Offerings
7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Company Information
7.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Product Offerings
7.8.5 Qingdao Jiulong Biopharmaceutical Recent Development
7.9 Opocrin
7.9.1 Opocrin Company Information
7.9.2 Opocrin Introduction and Business Overview
7.9.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Opocrin Heparin Product Offerings
7.9.5 Opocrin Recent Development
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Company Information
7.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
7.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Dongying Tiandong Pharmaceutical Heparin Product Offerings
7.10.5 Dongying Tiandong Pharmaceutical Recent Development
7.11 Aspen Oss
7.11.1 Aspen Oss Company Information
7.11.2 Aspen Oss Introduction and Business Overview
7.11.3 Aspen Oss Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Aspen Oss Heparin Product Offerings
7.11.5 Aspen Oss Recent Development
7.12 Yino Pharma
7.12.1 Yino Pharma Company Information
7.12.2 Yino Pharma Introduction and Business Overview
7.12.3 Yino Pharma Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Yino Pharma Heparin Product Offerings
7.12.5 Yino Pharma Recent Development
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Company Information
7.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Product Offerings
7.13.5 Nanjing Xinbai Pharmaceutical Recent Development
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Company Information
7.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
7.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Hubei Enoray Biopharmaceutical Heparin Product Offerings
7.14.5 Hubei Enoray Biopharmaceutical Recent Development
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Company Information
7.15.2 Cisen Pharmaceutical Introduction and Business Overview
7.15.3 Cisen Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Cisen Pharmaceutical Heparin Product Offerings
7.15.5 Cisen Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Heparin Industrial Chain
8.2 Heparin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Heparin Sales Model
8.5.2 Sales Channel
8.5.3 Heparin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Heparin Market Trends
Table 2. Heparin Market Drivers & Opportunity
Table 3. Heparin Market Challenges
Table 4. Heparin Market Restraints
Table 5. Global Heparin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Heparin Revenue Market Share by Company (2020-2025)
Table 7. Global Heparin Sales Volume by Company (2020-2025) & (B Units)
Table 8. Global Heparin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Heparin Price by Company (2020-2025) & (US$/B Units)
Table 10. Key Manufacturers Heparin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Heparin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Heparin
Table 13. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Heparin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Heparin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Heparin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Heparin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Heparin Sales Volume by Type: 2020 VS 2024 VS 2031 (B Units)
Table 22. Global Heparin Sales Volume by Type (2020-2025) & (B Units)
Table 23. Global Heparin Sales Volume by Type (2026-2031) & (B Units)
Table 24. Global Heparin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Heparin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Heparin Price by Type (2020-2025) & (US$/B Units)
Table 27. Global Heparin Price by Type (2026-2031) & (US$/B Units)
Table 28. Global Heparin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Heparin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Heparin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Heparin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Heparin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Heparin Sales Volume by Application: 2020 VS 2024 VS 2031 (B Units)
Table 34. Global Heparin Sales Volume by Application (2020-2025) & (B Units)
Table 35. Global Heparin Sales Volume by Application (2026-2031) & (B Units)
Table 36. Global Heparin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Heparin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Heparin Price by Application (2020-2025) & (US$/B Units)
Table 39. Global Heparin Price by Application (2026-2031) & (US$/B Units)
Table 40. Global Heparin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Heparin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Heparin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Heparin Sales Value by Region (2020-2025) & (%)
Table 44. Global Heparin Sales Value by Region (2026-2031) & (%)
Table 45. Global Heparin Sales Volume by Region (B Units): 2020 VS 2024 VS 2031
Table 46. Global Heparin Sales Volume by Region (2020-2025) & (B Units)
Table 47. Global Heparin Sales Volume by Region (2026-2031) & (B Units)
Table 48. Global Heparin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Heparin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Heparin Average Price by Region (2020-2025) & (US$/B Units)
Table 51. Global Heparin Average Price by Region (2026-2031) & (US$/B Units)
Table 52. Key Countries/Regions Heparin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Heparin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Heparin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Heparin Sales Volume, (2020-2025) & (B Units)
Table 56. Key Countries/Regions Heparin Sales Volume, (2026-2031) & (B Units)
Table 57. Shenzhen Hepalink Pharmaceutical Company Information
Table 58. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
Table 59. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 60. Shenzhen Hepalink Pharmaceutical Heparin Product Offerings
Table 61. Shenzhen Hepalink Pharmaceutical Recent Development
Table 62. Yantai Dongcheng Pharmaceutical Company Information
Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
Table 64. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 65. Yantai Dongcheng Pharmaceutical Heparin Product Offerings
Table 66. Yantai Dongcheng Pharmaceutical Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 70. Pfizer Heparin Product Offerings
Table 71. Pfizer Recent Development
Table 72. Bioibérica Company Information
Table 73. Bioibérica Introduction and Business Overview
Table 74. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 75. Bioibérica Heparin Product Offerings
Table 76. Bioibérica Recent Development
Table 77. Changzhou Qianhong Biopharma Company Information
Table 78. Changzhou Qianhong Biopharma Introduction and Business Overview
Table 79. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 80. Changzhou Qianhong Biopharma Heparin Product Offerings
Table 81. Changzhou Qianhong Biopharma Recent Development
Table 82. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 83. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
Table 84. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 85. Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offerings
Table 86. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 87. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 88. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
Table 89. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 90. Hebei Changshan Biochemical Pharmaceutical Heparin Product Offerings
Table 91. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 92. Qingdao Jiulong Biopharmaceutical Company Information
Table 93. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
Table 94. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 95. Qingdao Jiulong Biopharmaceutical Heparin Product Offerings
Table 96. Qingdao Jiulong Biopharmaceutical Recent Development
Table 97. Opocrin Company Information
Table 98. Opocrin Introduction and Business Overview
Table 99. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 100. Opocrin Heparin Product Offerings
Table 101. Opocrin Recent Development
Table 102. Dongying Tiandong Pharmaceutical Company Information
Table 103. Dongying Tiandong Pharmaceutical Introduction and Business Overview
Table 104. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 105. Dongying Tiandong Pharmaceutical Heparin Product Offerings
Table 106. Dongying Tiandong Pharmaceutical Recent Development
Table 107. Aspen Oss Company Information
Table 108. Aspen Oss Introduction and Business Overview
Table 109. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 110. Aspen Oss Heparin Product Offerings
Table 111. Aspen Oss Recent Development
Table 112. Yino Pharma Company Information
Table 113. Yino Pharma Introduction and Business Overview
Table 114. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 115. Yino Pharma Heparin Product Offerings
Table 116. Yino Pharma Recent Development
Table 117. Nanjing Xinbai Pharmaceutical Company Information
Table 118. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
Table 119. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 120. Nanjing Xinbai Pharmaceutical Heparin Product Offerings
Table 121. Nanjing Xinbai Pharmaceutical Recent Development
Table 122. Hubei Enoray Biopharmaceutical Company Information
Table 123. Hubei Enoray Biopharmaceutical Introduction and Business Overview
Table 124. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 125. Hubei Enoray Biopharmaceutical Heparin Product Offerings
Table 126. Hubei Enoray Biopharmaceutical Recent Development
Table 127. Cisen Pharmaceutical Company Information
Table 128. Cisen Pharmaceutical Introduction and Business Overview
Table 129. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 130. Cisen Pharmaceutical Heparin Product Offerings
Table 131. Cisen Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Heparin Downstream Customers
Table 135. Heparin Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Heparin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Heparin Sales Volume (2020-2031) & (B Units)
Figure 5. Global Heparin Sales Price (2020-2031) & (US$/B Units)
Figure 6. Heparin Report Years Considered
Figure 7. Global Heparin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Heparin Players Sales Volume Ranking (2024) & (B Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Revenue in 2024
Figure 10. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Heparin Sodium Picture
Figure 12. Heparin Calcium Picture
Figure 13. Global Heparin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Heparin Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Heparin Sales Volume by Type (2020 VS 2024 VS 2031) & (B Units)
Figure 16. Global Heparin Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Heparin Price by Type (2020-2031) & (US$/B Units)
Figure 18. Product Picture of UFH
Figure 19. Product Picture of LMWH
Figure 20. Global Heparin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Heparin Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Heparin Sales Volume by Application (2020 VS 2024 VS 2031) & (B Units)
Figure 23. Global Heparin Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Heparin Price by Application (2020-2031) & (US$/B Units)
Figure 25. North America Heparin Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Heparin Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Heparin Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Heparin Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Heparin Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Heparin Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Heparin Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Heparin Sales Volume (%), (2020-2031)
Figure 37. United States Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Heparin Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Heparin Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Heparin Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Heparin Sales Value by Application (%), 2024 VS 2031
Figure 43. China Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Heparin Sales Value by Type (%), 2024 VS 2031
Figure 45. China Heparin Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Heparin Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Heparin Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Heparin Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Heparin Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Heparin Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Heparin Sales Value by Application (%), 2024 VS 2031
Figure 55. India Heparin Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Heparin Sales Value by Type (%), 2024 VS 2031
Figure 57. India Heparin Sales Value by Application (%), 2024 VS 2031
Figure 58. Heparin Industrial Chain
Figure 59. Heparin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Heparin market?
The top companies in the global Heparin market are Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Pfizer.
Which region is expected to have the highest market share?
What was the global market size of Heparin in 2031?
What is the annual compound growth rate of the global Heparin market size from 2025 to 2031?
What was the global market size of Heparin in 2025?
Related Reports
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 92
USD 4250.00
(Single User License)
Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 121
USD 2900.00
(Single User License)
Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 130
USD 3950.00
(Single User License)
Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 166
USD 4900.00
(Single User License)
Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 113
USD 3950.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 93
USD 4250.00
(Single User License)
Global Heparin Market Research Report 2025
The global market for Heparin was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-08-27
Pages: 91
USD 2900.00
(Single User License)
Global Heparin Market Insights, Forecast to 2031
The global Heparin market is projected to grow from US$ 1966 million in 2025 to US$ 3083 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published Date: 2025-05-07
Pages: 150
USD 4900.00
(Single User License)
Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 147
USD 5900.00
(Single User License)
Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Heparin market size was US$ 1469 million in 2025 and is forecast to reach a readjusted size of US$ 2462 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 92
USD 4250.00 (Single User License)Global Heparin Market Research Report 2026
The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 121
USD 2900.00 (Single User License)Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Heparin was estimated to be worth US$ 1469 million in 2025 and is projected to reach US$ 2462 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 130
USD 3950.00 (Single User License)Global Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Heparin market is projected to grow from US$ 1225 million in 2024 to US$ 2301 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 166
USD 4900.00 (Single User License)Heparin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Heparin was estimated to be worth US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 113
USD 3950.00 (Single User License)Global Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Heparin market size was US$ 1225 million in 2024 and is forecast to a readjusted size of US$ 2301 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 93
USD 4250.00 (Single User License)Global Heparin Market Research Report 2025
The global market for Heparin was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-08-27
Pages: 91
USD 2900.00 (Single User License)Global Heparin Market Insights, Forecast to 2031
The global Heparin market is projected to grow from US$ 1966 million in 2025 to US$ 3083 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Published: 2025-05-07
Pages: 150
USD 4900.00 (Single User License)Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 147
USD 5900.00 (Single User License)Global Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now